Cure by age and stage at diagnosis for colorectal cancer patients in North West England, 1997-2004: A population-based study

Cancer Epidemiology

Volumn 36, Issue 6, 2012, Pages 548-553

  Shack, L G ^a,b   Shah, A ^c,d   Lambert, P C ^e,f   Rachet, B ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer registry; Colorectal cancer; Cure models; Population based study; Relative survival; Stage; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; COLORECTAL CANCER; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84868304170     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.06.011     Document Type: Article

References (41)

1. IARC World Cancer Report 2008 2008, IARC, Lyon, France. P. Boyle, B. Levin (Eds.).
2. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24(May 10 (14)):2137-2150.
3. Coleman M.P., Quaresma M., Berrino F., Lutz J.M., De Angelis R., Capocaccia R., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9(8):730-756.
4. Hayne D., Brown R.S.D., McCormack M., Quinn M.J., Payne H.A., Babb P. Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol 2001, 13:448-452.
5. Rachet B., Maringe C., Nur U., Quaresma M., Shah A., Woods L.M., et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009, 10(4):351-369.
6. Coleman M.P., Rachet B., Woods L.M., Mitry E., Riga M., Cooper N., et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004, 90:1367-1373.
7. Mitry E., Bouvier A.M., Esteve J., Faivre J. Improvement in colorectal cancer survival: a population-based study. Eur J Cancer 2005, 41:2297-2303.
8. Lambert P.C., Dickman P.W., Osterlund P., Andersson T., Sankila R., Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the finish cancer registry. Int J Cancer 2007, 121:2052-2059.
9. Vercelli M., Lillini R., Capocaccia R., Micheli A., Coebergh J., Quinn M., et al. Cancer survival in the elderly: effects of socio-economic factors and health care systems features (ELDCARE project). Eur J Cancer 2006, 42(2):234-242.
10. Guyot F., Faivre J., Manifefi S., Meny B., Bonithon-Kopp C., Bouvier A.M. Time trends in the treatment and survival from recurrence of colorectal cancer. Ann Oncol 2005, 16:756-761.
11. De Angelis R., Capocaccia R., Hakulinen T., Soderman B., Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999, 18:441-454.
12. Huang L., Cronin K.A., Mariotto A., Feuer E.J. Improved survival time: what can survival cure models tell us about population-based survival improvements in last-stage colorectal, ovarian and testicular cancer?. Cancer 2008, 112:2289-2300.
13. Francisci S., Capocaccia R., Grande E., Santaquilani M., Simonetti A., Allemani C., et al. The cure of cancer: a European perspective. Eur J Cancer 2009, 45(6):1067-1079.
14. Moller H., Richards S., Hanchett N., Riaz S.P., Luchtenborg M., Holmberg L., et al. Completeness of case ascertainment and survival time error in English registries; impact on 1 year survival estimates. Br J Cancer 2011, 105(1):170-176.
15. International Union AC TNM classification of malignant tumours 2004, Wiley-Liss, New York. C. Wittekind (Ed.).
16. Dukes C.E. The classification of cancer of the rectum. J Pathol Bacteriol 1932, 35:323.
17. Neighborhood Renewal Unit, Office of the Deputy, Prime Minister. The English indices of deprivation 2004 (revised). London: ODPM; 2004.
18. Charlson M.E., Pompei P., Ales K. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
19. Shack L.G., Rachet B., Williams E.M.I., Coleman M.P. Does the timing of comorbidity affect colorectal cancer survival? A population based study. Postgrad Med J 2010, 86:73-78.
20. Jack R.H., Davies E.A., Moller H. Testis and prostate cancer incidence in ethnic groups in South East England. Int J Androl 2007, 30:215-221.
21. Morris E., Haward R.A., Gilthorpe M.S., Craigs C., Forman D. The impact of the Calman-Hine report on the process and outcomes of care for Yorkshire colorectal cancer patients. Br J Cancer 2006, 95:979-985.
22. Rubin D.B. Multiple imputation for nonresponse in surveys 1987, John Whiley & Sons, New York.
23. Nur U., Shack L.G., Rachet B., Carpenter J.R., Coleman M.P. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol 2010, 39(1):118-128.
24. Berkson J., Gage R.P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clinic 1950, 25:270-286.
25. Lambert P.C. Modelling of the cure fraction in survival studies. Stata J 2007, 7:351-357.
26. Andersson T., Lambert P.C., Derolf A.R., Kistinsson S.Y., Elorant S., Langreen O., et al. Temporal trends in proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001: a population-based study. Br J Haematol 2009, 148:918-924.
27. Rubin D.B. Multiple imputation after 18+ years. J Am Stat Assoc 1996, 91:473-490.
28. Ederer F., Heise H. Instructions to IBM 650 programmers in processing survival computations (methodological note no. 10, end results evaluation section) 1959, National Cancer Institute, Bethesda.
29. STATA statistical software 9.0. College Station, TX: Stata Corporation; 2009 [Internet].
30. Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 2000, 284(8):1008-1015.
31. Phelip J.M., Molinie F., Delafosse P., Launoy G., Tretaree B., Bara S., et al. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers. Gastroenterol Clin Biol 2010, 34:144-149.
32. Quaglia A., Tamilla A., Shack L., Brenner H., Janssen-Heijnen M.L.G., Allemani C., et al. The cancer survival gap between elderly and middle aged patients in Europe is widening. Eur J Cancer 2009.
33. Golfinopoulos V., Pentheroudakis G., Pavlidis N. Treatment of colorectal cancer in the elderly: a review of the literature. Cancer Treat Rev 2006, 32:1-8.
34. Aparico T., Navazash A., Boutron I., Bouarioua N., Chosidow D., Mion M., et al. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Crit Rev Oncol Hematol 2009, 71(3):249-257.
35. Neal R.D., Allgar V.L. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the 'national survey of NHS patients: Cancer'. Br J Cancer 2005, 92:1971-1975.
36. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., Manfredi S., Dancourt V., Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 2002, 51:60-64.
37. Beaver K., Jones D., Susnerwala S., Craven O., Tomlinson M., Witham G., et al. Exploring the decision-making preferences of people with colorectal cancer. Health Expect 2005, 8:103-113.
38. Sant M., Allemani C., Berrino F., Coleman M., Aareleid T., Chaplan G., et al. Breast carcinoma survival in Europe and the United States: a population-based study. Cancer 2004, 100(4):715-721.
39. Sant M., Allemani C., Capocaccia R., Hakulinen T., Aareleid T., Coebergh J.W., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003, 106(January 9 (3)):416-422.
40. De Marco M.F., Janssen-Heijnen M.L.G., van der Heijden L.H., Coebergh J.W.W. Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer 2000, 36:95-99.
41. Woods L.M., Coleman M.P., Lawrence G., Rashbash J., Berrino F., Rachet B. Evidence against the proposition that " UK cancer survival statistics are misleading" : simulation study with national cancer registry data. BMJ 2011, 342:3399-3406.